UPDATED Mar 28, 2024
Ideas for first time investors to explore. This view looks for well-rounded established companies that pay dividends.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
OR | €438.65 | 0.9% | 8.2% | €234.6b | €439.71 | PE37.9x | E7.5% | 1.5% | Household | ||
TTE | €63.47 | 0.9% | 16.7% | €152.8b | €71.20 | PE7.7x | E-5.1% | 4.9% | Energy | ||
SAN | €90.96 | 3.7% | -8.5% | €113.6b | €107.63 | PE21x | E13.5% | 4.1% | Pharmaceuticals & Biotech | ||
DG | €118.76 | 1.7% | 12.7% | €67.8b | €133.33 | PE14.4x | E5.2% | 3.8% | Capital Goods | ||
SGO | €71.93 | 0.6% | 37.9% | €36.1b | €77.97 | PE13.5x | E8.0% | 2.9% | Capital Goods | ||
PUB | €101.05 | 2.2% | 39.2% | €25.3b | €105.19 | PE19.3x | E6.8% | 3.4% | Media | ||
AMUN | €63.65 | 1.3% | 10.8% | €12.9b | €74.20 | PE10.6x | E3.5% | 6.4% | Diversified Financials | ||
FGR | €105.15 | 0.5% | 5.5% | €10.1b | €122.50 | PE10x | E5.2% | 3.9% | Capital Goods | ||
IPN | €110.30 | 1.3% | 7.1% | €9.1b | €123.00 | PE14.8x | E5.6% | 1.1% | Pharmaceuticals & Biotech | ||
RXL | €25.03 | -1.1% | 14.3% | €7.4b | €26.38 | PE9.6x | E3.5% | 4.8% | Capital Goods | ||
AKE | €97.54 | 2.7% | 8.1% | €7.3b | €110.44 | PE18.2x | E15.5% | 3.6% | Materials | ||
SCR | €32.07 | 7.3% | 53.4% | €5.8b | €34.47 | PE7.1x | E4.3% | 5.6% | Insurance | ||
TEP | €90.08 | 1.9% | -59.7% | €5.5b | €164.41 | PE9.1x | E13.9% | 4.3% | Commercial Services | ||
RUI | €32.74 | 19.4% | 33.5% | €3.4b | €35.31 | PE9.5x | E2.6% | 5.9% | Utilities | ||
TRI | €163.00 | 11.1% | 38.1% | €3.1b | €182.71 | PE10.2x | E1.8% | 2.1% | Automobiles | ||
IPS | €65.35 | 1.3% | 13.9% | €2.9b | €73.71 | PE17.9x | E16.7% | 2.5% | Media | ||
BB | €66.20 | 3.9% | 12.8% | €2.8b | €77.33 | PE12.2x | E6.9% | 4.3% | Commercial Services | ||
TFI | €8.47 | 0.5% | 5.9% | €1.8b | €10.70 | PE9.3x | E6.5% | 6.5% | Media |